Treatment of Kaposi's sarcoma by inhibition of scatter factor
    5.
    发明授权
    Treatment of Kaposi's sarcoma by inhibition of scatter factor 失效
    通过抑制散射因子治疗卡波西氏肉瘤

    公开(公告)号:US5707624A

    公开(公告)日:1998-01-13

    申请号:US253728

    申请日:1994-06-03

    摘要: Methods of treating Kaposi's sarcoma (KS) by inhibiting the effect of scatter factor (SF), also known as hepatocyte growth factor (HGF), are provided. The methods of the present invention include antibody therapy wherein an antibody to SF is introduced into a patient to decrease active SF levels thereby decreasing the incidence of new tumors as well as leading to regression of established tumors by blocking SF-mediated tumor cell proliferation and neovascularization. The present invention further provides methods of inhibiting the effects of SF by introducing into a patient means for inhibiting binding of SF to the SF receptor, the c-met proto-oncogen. Means for inhibiting SF binding to the receptor include introducing into a patient an antibody to the c-met receptor or introducing a non-stimulatory ligand that will bind and thereby inhibit the receptor.

    摘要翻译: 提供了通过抑制散射因子(SF)(也称为肝细胞生长因子(HGF))的作用来治疗卡波西氏肉瘤(KS)的方法。 本发明的方法包括抗体治疗,其中将SF抗体引入患者以降低活性SF水平,从而降低新肿瘤的发生率,并通过阻断SF介导的肿瘤细胞增殖和新生血管形成导致建立的肿瘤的消退 。 本发明进一步提供了通过向患者引入SF抑制SF与SF受体,c-met原癌基因的结合来抑制SF的作用的方法。 用于抑制SF与受体结合的方法包括向患者施用对c-met受体的抗体或引入将结合并从而抑制受体的非刺激性配体。